Centre for Eye Research Australia
Glaucoma surgery is a highly effective way of preserving sight, but like most treatments, it comes with challenges.
The medicine that is currently used after surgery, which reduces scarring, is toxic and carries a risk of vision loss.
Now researchers from across CERA are working to investigate if gene therapy can be used to combat scarring instead.
“We want to go straight to the source of scarring,” says Dr Jennifer Fan Gaskin
/Public Release. View in full here.
